Influence of HLA on progression of optic neuritis to multiple sclerosis: results of a four-year follow-up study

Abstract

Background: Genetic predisposition in multiple sclerosis (MS) has always been a critical concern in aetiology and progress of the disease. The present study looks into the relations between human leukocyte antigen (HLA), optic neuritis (ON) and MS in the Iranian population. Methods: Patients with potential diagnosis of acute ON underwent a standardized clinical examination for confirming the diagnosis. Selected patients were gathered for HLA typing and clinical follow up. Results: Of the 55 patients, 46 (83.6%) were female. The mean age was 25(± 7.3) with a range of 12-43. Twenty of the 55 (36%) were confirmed for the diagnosis of clinically definite MS (CDMS). Results show that A23, B21, A11 and B51 alleles were present in 4 (20%), 6 (30%), 2 (10%) and 1 (5%) of the CDMS patients, respectively. Ten (50%) and 17 (85%) CDMS patients were positive for HLA class II alleles, DR2 and DQ1, correspondingly. Conclusions: The study strongly suggests the association among DR2, A23 and B21 allele and the evolution of ON to MS. High prevalence of A23 and DR2 alleles in CDMS patients compared with the normal population may suggest an important role for these alleles in the development of MS. The study suggests B51 as a protective factor against development of ON in the normal population. In addition, results do not confirm previous studies considering A11 as a predisposing factor. The present study finally evokes that different classes of HLA have different roles in susceptibility to MS and confirms disease heterogeneity as an important emerging concept in MS.

Keywords

HLA Iran multiple sclerosis optic neuritis

Get full access to this article

View all access options for this article.

References

Soderstrom M , Ya-Ping J , Hillert J , Link H. Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings . Neurology 1998; 50: 708-714 .

Soderstrom M. Optic neuritis and multiple sclerosis . Acta Ophthalmol Scand 2001; 79: 223-227 .

Barcellos LF , Oksenberg JR , Green AJ , Bucher P , Rimmler JB , Schmidt S et al. Genetic basis for clinical expression in multiple sclerosis . Brain 2002; 125: 150-158 .

Oksenberg JR , Baranzini SE , Barcellos LF , Hauser SL. Multiple sclerosis: genomic rewards . J Neuroimmunol 2001; 113: 171-184 .

Hauser SL , Oksenberg JR , Lincoln R , Garovoy J , Beck RW , Cole SR et al. Interaction between HLA-DR2 and abnormal MRI in optic neuritis and early MS . Neurology 2000; 54: 1859-1861 .

Kelly MA , Cavan DA , Penny MA , Mijovic CH , Jenkins D , Morrissey S et al. The influence of HLA-DR and -DQ alleles on progression to multiple sclerosis following a clinically isolated syndrome . Hum Immunol 1993; 37: 185-191 .

Uria DF. HLA and multiple sclerosis. Studies of a Spanish population . Rev Neurol 2000; 31: 1066-1070 .

Paty DW , Oger JJ , Kastrukoff LF , Hashimoto SA , Hooge JP , Eisen AA et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT . Neurology 1988; 38: 180-185 .

Boyum A. Isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 g . Scand J Clin Lab Invest 1968; 21: 77-89 .

10.

Terasaki PI , Bernoco D , Park MS , Ozturk G , Iwaki Y. Micro-droplet testing for HLA -A, B, C and D antigens . Am J Clin Pathol 1978; 69: 103-120 .

11.

Poser CM , Paty DW , Scheinberg L , McDonald WI , Davis FA , Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols . Ann Neurol 1983; 13: 227-231 .

12.

Barkhof F , Filippi M , Miller DH , Scheltens P , Campi A , Polman CH et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis . Brain 1997; 120: 2059-2069 .

13.

Nikbin B , Khosravi F , Kamgooyan M , Eliassian E , Halalzadeh A , Mohyeedin M et al. The distribution of class I and class II HLA antigens in Iranian population . In Aizawa A eds. Proceedings of the 3rd Asia-Oceania Histocompatibility Workshop Conference. Sapporo, Japan: Sapporo University Press, 1986: 552-555 .

14.

de Jong BA , Huizinga TW , Zanelli E , Giphart MJ , Bollen EL , Uitdehaag BM et al. Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region . Neurology 2002; 59: 549-555 .

15.

Kalanie H , Kamgooyan M , Sadeghian H , Kalanie AR. Histo-compatibility antigen (HLA) associations with multiple sclerosis in Iran . Mult Scler 2000; 6: 317-319 .

16.

Odinak MM , Bisaga GN , Kalinina NM , Akimov SB , Semilutskaia IB. Multiple sclerosis in Northern-West region of Russia: results of HLA-typing . Zh Nevrol Psikhiatr Im S S Korsakova 2000; 100: 40-44 .

17.

La Mantia L , Illeni MT , Milanese C , Salmaggi A , Eoli M , Pellegris G et al. HLA antigens in Italian multiple sclerosis patients . Ital J Neurol Sci 1991; 12: 81-86 .

18.

Lotfi J , Nikbin B , Derakhshan I , Aghai Z , Ala F. Histocompatibility antigens (HLA) in multiple sclerosis in Iran . J Neurol Neurosurg Psychiatry 1978; 41: 699-701 .

19.

Kankonkar S , Jeyanti G , Singhal BS , Shankarkumar U. Evidence for novel DRB1*15 allele association among clinically definite multiple sclerosis patients from Mumbai, India . Hum Immunol 2003; 64: 478-482 .

20.

Rubio JP , Bahlo M , Butzkueven H , van Der Mei IA , Sale MM , Dickinson JL et al. Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis . Am J Hum Genet 2002; 70: 1125-1137 .